DashboardPortfoliosWatchlistCommunityDiscoverScreener
NOT FOR DISTRIBUTION
Loading...
  • Stocks
  • /
  • Pharmaceuticals & Biotech
Updated 3h ago
A168330 logo

Naturalendo Tech Co., Ltd.KOSDAQ:A168330 Stock Report

Market Cap ₩75.1b
Updated 3h ago
Share Price
n/a
1Y-14.8%
7D1.1%
1D-1.7%
Portfolio Value
​
View

Naturalendo Tech Co., Ltd.

KOSDAQ:A168330 Stock Report

Market Cap: ₩75.1b

  • Company Overview
    • Valuation
    • Future Growth
    • Past Performance
    • Financial Health
    • Dividend
  • Management
  • Ownership
  • Other Information
  • Stock Community

Naturalendo Tech (A168330) Stock Overview

Engages in the research, development, manufacture, and sale of natural product new drugs, cosmetics, materials, food additives, and health functional food in South Korea. More details

A168330 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health3/6
Dividends0/6

Rewards

Earnings have grown 14.8% per year over the past 5 years

Risk Analysis

Has less than 1 year of cash runway

Does not have a meaningful market cap (₩75B)


A168330 Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

NEW433,395 members

Join community and earn perks

Gain real feedbackFrom our editorial team, personally. Not silence.
Grow your followingReal investors. The kind who actually invest, not scroll past.
Unlock free accessFree premium subscription for consistent and quality authors.
Learn moreCreate Narrative
B
BlackGoat
R
RockeTeller
I
Investingwilly
D
davidlsander
433,395 investors already sharing narratives
₩
Current Price
₩2.34k40.2% undervalued intrinsic discount
%/yr
Decrease
Increase
PastFuture-21b40b2016201920222025202620282031Revenue ₩40.0bEarnings ₩6.9b
Advanced
View all narratives

Naturalendo Tech Co., Ltd. Competitors

BIO-FD&CLtd

Symbol: KOSDAQ:A251120
Market cap: ₩79.2b

EyeGene

Symbol: KOSDAQ:A185490
Market cap: ₩84.9b

Optipharm.CO.LTD

Symbol: KOSDAQ:A153710
Market cap: ₩68.4b

GENINUS

Symbol: KOSDAQ:A389030
Market cap: ₩77.6b

Price History & Performance

Summary of share price highs, lows and changes for Naturalendo Tech
Historical stock prices
Current Share Price₩2,340.00
52 Week High₩4,100.00
52 Week Low₩1,668.00
Beta0.44
1 Month Change9.86%
3 Month Change13.04%
1 Year Change-14.75%
3 Year Change2.86%
5 Year Change-72.34%
Change since IPO-90.05%

Recent News & Updates

Analysis Article • Dec 05

There's No Escaping Naturalendo Tech Co., Ltd.'s (KOSDAQ:168330) Muted Revenues Despite A 36% Share Price Rise

Naturalendo Tech Co., Ltd. ( KOSDAQ:168330 ) shares have had a really impressive month, gaining 36% after a shaky...
Analysis Article • Nov 20

Would Naturalendo Tech (KOSDAQ:168330) Be Better Off With Less Debt?

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...

Recent updates

Analysis Article • Dec 05

There's No Escaping Naturalendo Tech Co., Ltd.'s (KOSDAQ:168330) Muted Revenues Despite A 36% Share Price Rise

Naturalendo Tech Co., Ltd. ( KOSDAQ:168330 ) shares have had a really impressive month, gaining 36% after a shaky...
Analysis Article • Nov 20

Would Naturalendo Tech (KOSDAQ:168330) Be Better Off With Less Debt?

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Analysis Article • Jul 11

Naturalendo Tech Co., Ltd.'s (KOSDAQ:168330) 32% Dip In Price Shows Sentiment Is Matching Revenues

Naturalendo Tech Co., Ltd. ( KOSDAQ:168330 ) shares have retraced a considerable 32% in the last month, reversing a...
Analysis Article • May 20

Naturalendo Tech Co., Ltd. (KOSDAQ:168330) Stock Catapults 29% Though Its Price And Business Still Lag The Industry

Despite an already strong run, Naturalendo Tech Co., Ltd. ( KOSDAQ:168330 ) shares have been powering on, with a gain...
Analysis Article • Apr 03

Naturalendo Tech Co., Ltd.'s (KOSDAQ:168330) Price Is Right But Growth Is Lacking

You may think that with a price-to-sales (or "P/S") ratio of 2.3x Naturalendo Tech Co., Ltd. ( KOSDAQ:168330 ) is...
Analysis Article • Nov 13

Naturalendo Tech Co., Ltd. (KOSDAQ:168330) Looks Inexpensive But Perhaps Not Attractive Enough

With a price-to-sales (or "P/S") ratio of 1.9x Naturalendo Tech Co., Ltd. ( KOSDAQ:168330 ) may be sending very bullish...
Analysis Article • Mar 26

Is Naturalendo Tech (KOSDAQ:168330) A Risky Investment?

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...

Shareholder Returns

A168330KR BiotechsKR Market
7D1.1%-0.4%4.9%
1Y-14.8%-18.5%90.6%

Return vs Industry: A168330 exceeded the KR Biotechs industry which returned -18.5% over the past year.

Return vs Market: A168330 underperformed the KR Market which returned 90.6% over the past year.

Price Volatility

Is A168330's price volatile compared to industry and market?
A168330 volatility
A168330 Average Weekly Movement6.3%
Biotechs Industry Average Movement11.6%
Market Average Movement8.8%
10% most volatile stocks in KR Market16.2%
10% least volatile stocks in KR Market4.2%

Stable Share Price: A168330 has not had significant price volatility in the past 3 months compared to the KR market.

Volatility Over Time: A168330's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
200183Hee-do Kimwww.naturalendo.co.kr

Naturalendo Tech Co., Ltd. engages in the research, development, manufacture, and sale of natural product new drugs, cosmetics, materials, food additives, and health functional food in South Korea. The company offers EstroG-100, a functional raw material for women's menopause; HabaNova, a diet material; YGF 251, a phyto height growth booster; NET 2401, a multiway sleep-wake cycle regulator; Stauntonia hexaphylla Fruit Extract, an anti-inflammatory superfood; Q.186 complex for improving male menopause; NET 1701, a ultimate men’s prostate and urinary support; and Quercus acuta Thunb. fruit extract for preventing skin aging caused by ultraviolet rays.

Naturalendo Tech Co., Ltd. Fundamentals Summary

How do Naturalendo Tech's earnings and revenue compare to its market cap?
A168330 fundamental statistics
Market cap₩75.14b
Earnings (TTM)-₩1.63b
Revenue (TTM)₩22.79b
3.2x
P/S Ratio
-45.3x
P/E Ratio

Is A168330 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
A168330 income statement (TTM)
Revenue₩22.79b
Cost of Revenue₩12.66b
Gross Profit₩10.14b
Other Expenses₩11.77b
Earnings-₩1.63b

Last Reported Earnings

Jun 30, 2026

Next Earnings Date

n/a

Earnings per share (EPS)-51.71
Gross Margin44.47%
Net Profit Margin-7.16%
Debt/Equity Ratio45.7%

How did A168330 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/09/22 08:50
End of Day Share Price 2026/09/22 00:00
Earnings2026/06/30
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
  • SEC Form 10-K
  • SEC Form 10-Q
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
  • Analyst Research Reports
  • Blue Matrix
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
  • ICE Market Data
  • SEC Form S-1
Ownership10 years
  • Top shareholders
  • Insider trading
  • SEC Form 4
  • SEC Form 13D
Management10 years
  • Leadership team
  • Board of directors
  • SEC Form 10-K
  • SEC Form DEF 14A
Key Developments10 years
  • Company announcements
  • SEC Form 8-K

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Naturalendo Tech Co., Ltd. is covered by 7 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Hyuk Jin YoonEugene Investment & Securities Co Ltd.
Dong Ha KimKyobo Securities Co., Ltd
Gi KimLS Securities Co., Ltd.

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide